売上高・売上総利益率の推移
| 年度 |
売上高 |
売上総利益率 |
| 2025/2 |
35,608 |
7.8% |
| 2024/2 |
35,792 |
10.8% |
| 2023/2 |
34,054 |
6.8% |
| 2022/2 |
22,927 |
12.3% |
| 2021/2 |
16,684 |
9.9% |
| 2019/2 |
1,473 |
|
| 2018/2 |
454 |
|
| 2017/2 |
14 |
|
| 2016/2 |
15 |
|
| 2015/2 |
14 |
|
営業利益・営業利益率の推移
| 年度 |
営業利益 |
営業利益率 |
| 2025/2 |
-5,949 |
-16.7% |
| 2024/2 |
-3,818 |
-10.7% |
| 2023/2 |
-6,666 |
-19.6% |
| 2022/2 |
-4,867 |
-21.2% |
| 2021/2 |
-4,225 |
-25.3% |
| 2019/2 |
-2,565 |
|
| 2018/2 |
-1,750 |
|
| 2017/2 |
-13 |
|
| 2016/2 |
-13 |
|
| 2015/2 |
-76 |
|
|
(単位:千ドル)
|
2015/2
|
2016/2
|
2017/2
|
2018/2
|
2019/2
|
2021/2
|
2022/2
|
2023/2
|
2024/2
|
2025/2
|
|
売上高
|
14
|
14
|
14
|
453
|
1,473
|
16,683
|
22,927
|
34,054
|
35,791
|
35,607
|
|
売上成長率(%)
|
-
|
|
|
|
|
-
|
37.4
|
48.5
|
5.1
|
-0.5
|
|
売上原価
|
6
|
6
|
6
|
434
|
1,130
|
15,036
|
20,113
|
31,735
|
31,929
|
32,843
|
|
売上総利益
|
7
|
8
|
7
|
18
|
343
|
1,646
|
2,814
|
2,318
|
3,861
|
2,763
|
|
売上総利益率(%)
|
|
|
|
|
|
9.9
|
12.3
|
6.8
|
10.8
|
7.8
|
|
研究開発費
|
-
|
-
|
-
|
-
|
-
|
552
|
923
|
797
|
699
|
632
|
|
営業費用
|
83
|
20
|
21
|
1,768
|
2,907
|
5,871
|
7,681
|
8,984
|
7,679
|
8,712
|
|
営業利益
|
-76
|
-13
|
-14
|
-1,750
|
-2,565
|
-4,226
|
-4,868
|
-6,667
|
-3,818
|
-5,950
|
|
営業利益率 (%)
|
|
|
|
|
|
-25.3
|
-21.2
|
-19.6
|
-10.7
|
-16.7
|
|
経常(税引前)利益
|
-77
|
-
|
-
|
-
|
-
|
-
|
-4,941
|
-7,539
|
-3,813
|
-5,989
|
|
経常(税引前)利益率(%)
|
-533.2
|
-
|
-
|
-
|
-
|
-
|
-21.5
|
-22.1
|
-10.7
|
-16.8
|
|
法人税等合計
|
0
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-880
|
|
実効税率(%)
|
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
14.7
|
|
純利益
|
-77
|
-14
|
-14
|
-1,742
|
-2,913
|
-4,379
|
-4,941
|
-7,539
|
-3,758
|
-5,110
|
|
純利益率(%)
|
|
|
|
|
|
-26.2
|
-21.5
|
-22.1
|
-10.5
|
-14.3
|
|
一株あたり利益
|
-
|
-
|
-
|
-0.15
|
-0.12
|
-0.13
|
-0.12
|
-0.17
|
-0.07
|
-0.09
|
|
希薄化後一株あたり利益
|
-
|
-
|
-
|
-0.15
|
-0.16
|
-0.13
|
-0.12
|
-0.17
|
-0.07
|
-0.09
|
|
EBITDA
|
-
|
-
|
-
|
|
|
-4,199
|
-4,810
|
-6,603
|
-3,747
|
-5,903
|
|
EBITDAマージン(%)
|
-
|
-
|
-
|
|
|
-25.2
|
-21.0
|
-19.4
|
-10.5
|
-16.6
|